TP53 and breast cancer: These genes are plausible candidates to account for the fact that BRCA-negative HBC families as heterozygous carriers of PVs in these genes also have significant absolute risks for premenopausal BC: exceeding 60% for TP53 carriers [7] and 40–60% for STK11 carriers [7].